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Abstract
Background: Prothrombin time-international normalized ratio (PT-INR) is widely utilized to guide plasma
therapy and initiation of thromboprophylaxis after a hepatectomy. Thrombelastography (TEG) monitors
shear elasticity, which is sensitive to cellular and plasma components in blood, allowing for functional
assessment of the life of the clot. The objective of this study was to prospectively compare PT-INR and
TEG in liver resection patients.
Methods: Forty patients were enrolled before undergoing an elective hepatectomy. Patients underwent
a liver resection utilizing a low central venous pressure (CVP) anaesthetic technique and intermittent
Pringle manoeuver. PT-INR and TEG were drawn prior to incision, post-operatively, and post-operative
days 1, 3 and 5.
Results: All post-operative PT-INR values increased significantly when compared with pre-operative
PT-INR (P < 0.01). The time of onset to clot (R-value) decreased significantly at the post-operative time
point (P = 0.04), consistent with a relative hypercoagulability. Subsequent R-values were not different
compared with the pre-operative R-value. The strength of the clot (maximum amplitude, MA) was
unchanged when comparing pre- and post-operative time points.
Discussion: In spite of an elevation in PT-INR, patients undergoing a liver resection demonstrated a brief
hypercoagulable state, followed by normal coagulation function based on TEG. These data call into
question the practice of utilizing PT-INR to guide plasma transfusion and timing of prophylactic antico-
agulation after a liver resection.
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Introduction
A partial hepatectomy is a common surgical therapy for both
benign and malignant hepatic disease. Advances in surgical tech-
nique over the past 30 years have led to decreased peri-operative
blood product transfusion,morbidity andmortality.While a post-
operative elevation in prothrombin time-international normal-
ized ratio (PT-INR) has been well characterized, the clinical
significance of a prolonged PT-INR in the post-operative period
remains poorly understood.1–3
Previous studies have suggested that changes in liver function
tests may vary and clinically correlate with the extent of a hepatic
resection. Liver parenchymal enzymes such as serum glutamic
oxaloacetic transaminase (SGOT), alkaline phosphatase, and total
bilirubin all increase after both anatomic resections and smaller
wedge resections.1 Liver resection leads to a transient decrease
in synthetic function of the liver, resulting in impaired synthesis
of clotting factors and regulatory proteins in the coagulation
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cascade.4 An associated elevation of the PT-INR after a liver resec-
tion is a common finding, and has been reported in multiple
previous studies.1–7 Prospective studies have shown that the
PT-INR remains elevated until post-operative day 5 compared
with the pre-operative value.3
The clinical implications of an elevated PT-INR are numerous.
Elevation of PT-INR frequently leads to post-operative transfu-
sion of fresh frozen plasma (FFP) in liver resection patients. A
transfusion is associated with the risks of infection, fluid overload,
anaphylaxis and transfusion-related acute lung injury (TRALI).8,9
Thromboprophylaxis is considered the standard of care after
major abdominal operations owing to the associated risk of a deep
vein thrombosis (DVT) and pulmonary embolism (PE) and it is
frequently delayed because of an elevated PT-INR.10–12 While
reported rates of venous thromboembolism (VTE) vary in the
literature, data exist suggesting that withholding thromboprophy-
laxis leads to a higher rate of clinically significant VTE.
Thrombelastography (TEG) is a point-of-care test that meas-
ures shear elasticity of a blood clot using whole blood, making it
sensitive to changes in both plasma and cellular components in
blood. TEG has been studied in trauma,13 liver transplantation,14,15
orthopaedic,16 urological17 and cardiac patients.18 Previous studies
have demonstrated that TEG is superior to PT-INR for evaluating
the coagulation status in critically ill patients.19–21 When compar-
ing TEG to INR in living donor liver transplantation, Cerutti et al.
demonstrated a hypercoagulable state in some patients in spite of
an elevated PT-INR.14
Alterations in coagulation after a partial hepatectomy remain
poorly understood and difficult to predict. The impaired synthesis
of pro- and anticoagulant factors after liver resection results in a
functional coagulation status that is largely unknown. The aim of
this study was to characterize the peri-operative coagulation
profile of patients undergoing a liver resection using both routine
coagulation tests and TEG.
Methods
Patients
This study was designed as a prospective, non-interventional trial.
The protocol was approved by the Institutional Review Board at
Oregon Health & Science University. Patients scheduled to
undergo an elective anatomic hepatic resection were screened.
Informed consent was obtained from all patients prior to partici-
pation in the study. Demographics were collected from the
patients including: age, gender, diagnosis, presence of cirrhosis,
American Society of Anesthesiologists Physical Status Classifica-
tion (ASA Class) and body mass index (BMI).
Standard laboratory tests
PT-INR, activated partial thromboplastin time (aPTT), platelet
and fibrinogen assays were performed at the Oregon Health &
Science University Core Laboratory. These studies were obtained
at the pre-operative clinic appointment or on the day of surgery
prior to the operation, 5 h after the completion of the operation
(3 h), and on post-operative days 1, 3 and 5.
Thrombelastography
Blood samples were obtained from participants on the day of
surgery prior to the operation, 5 h after the completion of the
operation (3 h), and on the mornings of post-operative days 1,
3 and 5. Studies were performed on fresh non-citrated specimens
utilizing kaolin to accelerate clotting. Heparinase-containing cups
were also used if the patient was receiving prophylactic, low-
molecular-weight heparin (LMWH). The Thrombelastograph
Haemostasis Analyzer 5000 (Haemoscope, Skokie, IL, USA) was
utilized for the analyses. TEG values were recorded and analyzed.
Caregivers were blinded to the results of the TEGs and they were
not used to make clinical decisions in this study.
Operative procedure
Administration of anaesthesia and peri-operative care was rou-
tinely performed by the attending anaesthesiologist. Epidural
analgesia was offered to patients as deemed appropriate by the
attending anaesthesiologist. Low central venous pressure (CVP)
techniques were used during a partial hepatectomy, and an inter-
mittent Pringle manoeuver was performed at the preference of the
attending surgeon. The target CVP was less than 5 mmHg.Opera-
tion, operative time, estimated blood loss and Pringle time were
recorded.
Post-operative course
All patients were taken to the intensive care unit post-operatively
for routine care. Patients were monitored prospectively for blood
product transfusion and venous thromboembolism (VTE).
Patients in the intensive care unit underwent weekly screening
duplex ultrasound exams per institutional protocol. Patients on
the acute care units underwent duplex ultrasound examinations if
symptoms of VTE developed.
Statistical analysis
Parametric, normally distributed data were compared using Stu-
dent’s t-test, and values are presented as mean standard error of
the mean (SEM). Non-normally distributed data were compared
using the Mann–Whitney U-test, and values are presented as
median with interquartile range (IQR). Normally distributed data
comparison within groups utilized a paired t-test, whereas non-
parametric data comparisons within groups were assessed using a
Kruskal–Wallis test. Statistical package software SPSS, version 19.0
(SPSS Inc., Chicago, IL, USA) was utilized for all statistical com-
parisons. Statistical significance was defined as a P-value <0.05.
Results
Forty patients were enrolled in the study after informed consent
was obtained. Five patients were excluded after undergoing a
minor hepatectomy (four patients) or a palliative hepaticojeju-
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nostomy for metastatic disease (one). Of the remaining 35
patients, the mean age was 59.9 years (Table 1). Eighteen patients
were male. Thirty-one of the 35 patients underwent a partial
hepatectomy for malignancy, most commonly metastatic colorec-
tal cancer (16 of 35, Table 1). Five patients had evidence of
cirrhosis on final pathology, and the most common ASA classifi-
cation was 3 (24 of 35, Table 1).
The distribution of operative procedures is listed in Table 2.
The most common operation performed was a right hepatectomy
(16 of 35). The median estimated blood loss was 400 ml (range
50–18 000), and the mean operative time was 303.6  114 min.
Twelve patients underwent an intermittent Pringle manoeuver,
with a mean total time of 16.8 min.
Pre-operative PT-INR was found to be within normal limits for
all patients (Table 3). After the operation, PT-INR values were
noted to be significantly elevated at all time points, with a peak
median value of 1.4 on post-operative day 3 (Fig. 1). Values
remained elevated through post-operative day 5, at the comple-
tion of the study.
The median aPTT was found to decrease significantly after the
operation (Table 3). It subsequently rose in the post-operative
setting, peaking at post-operative day 3 at 34.1. In spite of a
significant elevation on post-operative days 3 and 5, the aPTT was
found to be within the normal range for the duration of the study
(Fig. 2).
Fibrinogen decreased significantly after a partial hepatectomy
(Table 3), but remained within normal limits. By post-operative
day 3, the fibrinogen had increased above pre-operative levels and
remained significantly elevated on post-operative day 5 (Fig. 3).
Platelet counts remained unchanged immediately after a partial
hepatectomy, but decreased significantly on post-operative day 1
(Table 3, Fig. 4). Counts continued to decrease on post-operative
day 3, but recovered to normal levels on post-operative day 5.
The time to initiation of a clot (R-value) was noted to be within
the normal range pre-operatively for all patients (Table 4). At the
post-operative time point, the R-value was significantly lower, but
still within the normal limits. No statistically significant differ-
ences in R-value were noted at the remaining time points. The
strength of clot (maximum amplitude, MA) did not change sig-
nificantly at any time point (Table 4). The rate at which the clot
strengthened (a-Angle) and the complete coagulation profile as
assessed by TEG (coagulation index, CI) were unchanged at all
time points.
Four patients in the study underwent a fresh frozen plasma
transfusion post-operatively. Of those, one received FFP immedi-
ately after the operation for an elevated intra-operative PT-INR.
Two patients had a TEG and standard coagulation assays per-
formed on the morning of the transfusion (Table 5). TEG on both
of those patients demonstrated s normal R-value and MA, sug-
gesting normal coagulation. A third patient was transfused on
post-operative day 2, a day in which TEG was not performed, and
developed a febrile non-haemolytic reaction.
Two patients had venous thromboembolic events after a partial
hepatectomy. Of these, one was a pulmonary embolism approxi-
mately 3months after the operation, in a patient who received FFP
for an elevated INR. At the time of FFP transfusion, that patient
had a normal TEG and a shortened aPTT. LMWH prophylaxis
was started on this patient on the evening of post-operative day 2.
The second patient developed a deep vein thrombosis at the site of
a central venous catheter on post-operative day 9, after LMWH
prophylaxis was initiated on post-operative day 4. While this
patient’s post-operative day 1 INR was 1.65, the R-time by TEG
was 3.7 min, suggesting a transient hypercoagulable state by TEG.
On post-operative day 5, after initiation of LMWH, the R-time
was found to be 18.8 min by standard kaolin TEG and 7.3 min by
heparinase TEG.
Table 1 Patient demographics including mean age, gender, diagno-
sis, pathological presence of cirrhosis, body mass index (BMI) and
American Society of Anesthesiologists (ASA) physical status class
Demographics
Age – year, mean (range, SD) 59.9 (32–88, 12.7)
Male – no. of patients 18
Diagnosis – no. of patients
Metastatic colorectal cancer 16
Hepatocellular carcinoma 8
Cholangiocarcinoma 3
Gallbladder cancer 2
Othera 6
Cirrhosis – no. of patients 5
BMI – mean (range, SD) 26.5 (19.7–34.4, 4.5)
ASA Class – no. of patients
2 6
3 24
4 3
aIncludes focal nodular hyperplasia, renal cell carcinoma, neuroendocrine
tumour, hepatoma and hepatic hemangioma.
Table 2 Operative details including operation performed, estimated
blood loss, operating room time and use of a Pringle manoeuver
Operative details
Operation – no. of patients
Right hepatectomy 17
Left hepatectomy 7
Extended right hepatectomy 2
Left lateral segmentectomy 2
Minor resection (2 or fewer sections) 7
Estimated blood loss (ml) – median (range) 400 (50–18,000)
Operating room time (min) – mean (range, SD) 303.6 (177–648, 114)
Pringle Manoeuver
No. of patients 12
Length of time (min) – mean (range, SD) 16.75 (8–32, 8.8)
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Discussion
PT-INR has been used to guide FFP transfusion and the initiation
of thromboembolic prophylaxis after a partial hepatectomy, in
spite of an incomplete understanding of the effect of a partial
hepatectomy on the coagulation cascade. Multiple previous
studies have shown that TEG is a better predictor of hypercoagu-
lable and coagulopathic states when compared with PT-INR in
cardiac and trauma patients.9,13,19–21 In the largest currently pub-
lished series on TEG in partial hepatectomy, Cerruti et al. pub-
lished an observational study of 10 patients undergoing a right
hepatectomy for living donor liver transplantation.14 In their
study, 4 out of 10 patients demonstrated hypercoagulability on
TEG by post-operative day 5 and 6 out of 10 patients were hyper-
coagulable on post-operative day 10. One patient who demon-
strated hypercoagulability on day 5 by TEG developed a DVT on
day 8.
In the present study, the PT-INR demonstrated a coagulopathic
state with median values persisting above the normal limits of the
test at the completion of the study. In contrast, TEG demonstrated
normal coagulation function in these patients, with a transient
relative hypercoagulability immediately after a partial hepatec-
tomy. aPTTmeasurements were similar to the TEG findings, dem-
onstrating a transient decrease but remaining within the normal
limits for the duration of the study.
The difference observedmay be attributable to the nature of the
tests. Unlike traditional coagulation assays, which measure com-
ponents of blood and portions of the coagulation pathway sepa-
rately, TEG uses whole blood to measure functional coagulation.
This allows for active involvement of the red blood cell, white
blood cell, platelet and plasma components of coagulation. Addi-
tionally, TEG measures the rate of formation, stabilization and
lysis of the clot, to give a more complete picture of the coagulation
Table 3 Standard coagulation assays
Time point INR (IQR) aPTT (IQR) Fibrinogen (IQR) Platelets (IQR)
(Ref range 0.8–1.2) (Ref range 26–36 s) (Ref range 200–450 mg/dl) (Ref range 150–400 k/cu
mm)
Pre-operative 1.0 (1.0, 1.1) 30.1 (27.8, 32.3) 412 (310, 468) 184 (161, 256)
Post-operative 1.2 (1.2, 1.3)a 29.1 (26.7, 31.1)b 294 (230, 347)a 183 (139, 262)
POD #1 1.4 (1.2, 1.4)a 30.0 (27.6, 31.7) 294 (255, 367)a 165 (132, 214)a
POD #3 1.4 (1.3, 1.5)a 34.1 (32.5, 36.3)a 451 (314, 540)b 134 (93, 192)a
POD #5 1.3 (1.2, 1.4)a 32.9 (30.9, 37.1) b 448 (403, 552)b 176 (115, 214)a
International normalized ratio (INR) rose significantly after a hepatectomy. Activated partial thromboplastin time (aPTT) remained within normal limits.
Fibrinogen decreased dramatically, and then rose beyond pre-operative values. Platelets decreased post-operatively, but trended towards recovery
at the end of the study.
IQR, interquartile range; POD, post-operative day.
aP < 0.01.
bP < 0.05.
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Figure 1 International normalized ratio (INR) rose significantly after a
hepatectomy, suggesting coagulopathy
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Figure 2 Median activated partial thromboplastin time (aPTT)
remained within normal limits in spite of statistically significant
changes
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status of the patient. PT-INR specifically measures factors II, V,
VII, X and fibrinogen activity using platelet-poor plasma, which
have been previously shown to decrease in the setting of a partial
hepatectomy.22
The transient decreases in fibrinogen and platelet counts
suggest the formation of fibrin–platelet complexes, and the suc-
cessful formation of a blood clot. Both fibrinogen and platelets are
inflammatory markers, and both demonstrate a subsequent rise
consistent with a post-operative pro-inflammatory state.
Normal coagulation is likely maintained by a combination of
factors. While poorly understood, it is commonly accepted that a
pro-coagulant state occurs after major abdominal surgery. In
addition, the decreased synthetic function of the liver after a
partial hepatectomy leads to a concomitant decrease in both pro-
and anti-coagulant factors. Additionally, previous studies have
demonstrated a transient increase in factor VIII and von Willen-
brand’s factor, which are not synthesized in the liver.22 In decreas-
ing all hepatically synthesized factors concurrently, and
up-regulating non-hepatically synthesized factors, the coagulation
system appears to maintain a near-normal coagulation.
With regard to the use of FFP in the treatment of presumed
coagulopathy associated with elevation of the PT-INR, four
patients were transfused with FFP post-operatively in the present
study. Two of the patients had both TEG and complete coagula-
tion assays performed on the morning prior to the transfusion of
FFP (Table 4), and received plasma solely for elevated INR and
concern for bleeding risk. In spite of an elevated PT-INR in both
patients at the time of the morning lab draws and in the afternoon
prompting a transfusion, neither demonstrated evidence of
coagulopathy by TEG. Of these two patients, one actually had an
aPTT value that was below normal limits, suggesting hypercoagu-
lability, and was found to have an incidentally noted sub-
segmental PE on chest CT approximately 3 months after a partial
hepatectomy. No patients in the study had clinical evidence of
persistent bleeding owing to coagulopathy.
After a partial hepatectomy, thromboembolic prophylaxis is
frequently delayed based on the belief that an elevated PT-INR is
associated with ‘auto-prophylaxis’ against thromboembolism. The
results presented suggest that in spite of an elevated PT-INR, these
patients maintained a normal coagulation function, and did not
have an inherent coagulopathy that would preclude the formation
of deep vein thrombosis. In fact, of the two patients withVTE,both
demonstrated evidence of hypercoagulability on assays drawn con-
currently with elevated PT-INR. While these patients did receive
thromboembolic prophylaxis prior to thediagnosis ofVTE, inboth
cases there was evidence of hypercoagulability prior to the initia-
tion of LMWH. The median PT-INR peaked at 1.4, which some
hepato-biliary surgeons would consider clinically insignificant. It
should be noted that this is a median among 35 patients, meaning
half of these patients demonstrated a PT-INR above this value, and
would represent a group where concern for bleeding may lead to a
delay in thromboembolic prophylaxis or treatment with FFP.
Several limitations exist in this study. While it is the largest
series directly comparing TEG to PT-INR in patients after a partial
hepatectomy, at 35 patients it remains inadequately powered
to compare the effects of potential confounders in this patient
population. These include usage or duration of the Pringle
manoeuver, the presence of pre-existing liver disease, duration of
surgery, extent of the resection and blood loss. Enrolment of addi-
tional patients would permit a multivariable analysis to analyse
the potential effects of these factors. Finally, this study contains a
heterogeneous series of operations and indications, both malig-
nant and benign.
In conclusion, patients undergoing a partial hepatectomy for
benign and malignant disease demonstrated normal functional
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Figure 3 Fibrinogen declined after a hepatectomy, then rose above
pre-operative values
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Figure 4 Platelets declined on post-operative days 1 and 3, but
began to trend up by post-operative day 5
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coagulation after surgery, in spite of an an elevation in the
PT-INR.While PT-INR is a strong indicator of synthetic function
of the liver, TEG better characterizes functional coagulation in
these patients. As it is an inadequate predictor of functional
coagulation, PT-INR should not be used to guide the decision to
transfuse FFP or to initiate or delay thromboembolic prophylaxis
after a partial hepatectomy.
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